Bladder Cancer Research Innovation Awardees

Meet Our Funded Investigators

Since 2009, the Bladder Cancer Advocacy Network (BCAN) has invested nearly $6 million for bladder cancer research.

The BCAN Bladder Cancer Research Innovation Awards support high risk, high reward projects with great potential to produce breakthroughs in our understanding of bladder cancer. These awards are available to full time, independent investigators affiliated with non-profit academic, medical or research institutions within the United States or Canada. Awardees include:

2021

Weiguo Cui, PhD
Associate Investigator at the Versiti Blood Research Institute and an Associate Professor of Microbiology and Immunology at the Medical College of Wisconsin

Research: Discovering what factors lead to T cell exhaustion and finding ways to reverse it.

Read more

Weiguo Cui, PhD, an Associate Investigator at the Versiti Blood Research Institute

2021

John K. Lee, MD, PhD
Assistant Professor in the Human Biology Division at the Fred Hutchinson Cancer Research Center

Research: Inform new and effective treatment strategies for those suffering from variant bladder cancers.

Read more

John K. Lee, M.D., Ph.D., Assistant Professor in the Human Biology Division at the Fred Hutchinson Cancer Research Center.

2020
Jeffrey Ravetch, MD, PhD
Professor, Rockefeller University

Research: “Intravesical delivery of FC-enhanced CD40 against antibody for the treatment of bladder cancer.”

Read more

2019
Philip Beachy, PhD
Professor, Stanford University School of Medicine

Research: “Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer.”

Read more

2018
Michael M. Shen, PhD
Professor, Columbia University Irving Cancer Center

Research: “Modeling bladder cancer metastasis using human patient-derived tumor organoids.”

Read more

2017
Seth Lerner, MD, FACS
Chair of Urologic Oncology, Baylor College of Medicine

Research: “Proteogenomic characterization of MIBC to identify mechanisms of resistance and targets for therapy.”

Read more

2016
David McConkey, PhD
Director, Johns Hopkins Greenberg Bladder Cancer Institute
The JPB Foundation Bladder Cancer Research Innovations Award

Research: “Targeting FGFR3 in muscle-invasive bladder cancer.”

2015
Cory Abate-Shen, PhD
Professor of Urological Oncology, Columbia University Medical Center
Associate Director of Translational Research, Herbert Irving Comprehensive Cancer Center

James Family Foundation and Partner Fund Management Bladder Cancer Research Innovations Award

Research: “Epigenetic regulation of bladder cancer progression.”

2014

William Kim, MD
Associate Professor, University of North Carolina at Chapel Hill
The JPB Foundation Bladder Cancer Research Innovations Award

Research: “Immune Characterization of High-Grade Bladder Cancer.”